Literature DB >> 2820143

Intergenic sequences of the vesicular stomatitis virus genome (New Jersey serotype): evidence for two transcription initiation sites within the L gene.

D Luk, P S Masters, D S Gill, A K Banerjee.   

Abstract

The intergenic sequences of vesicular stomatitis virus of the New Jersey serotype [VSV (NJ): Ogden strain] have been determined by dideoxy sequencing across the gene junctions of the viral RNA genome using deoxyoligonucleotide primers. The N-NS, NS-M, and M-G intergenic sequences of VSV (NJ) are identical to the consensus intergenic sequence for VSV of the Indiana serotype [VSV (IND)]: 3'-AUACU7GAUUGUCNNNAG-5' (genome sense; N denotes any nucleotide), where 3'-AUACU7-5' encodes the 3' terminus and the start of the polyadenylate tract of the preceding mRNA, 3'-UUGUCNNNAG-5' encodes the 5' terminus of the succeeding mRNA, and 3'-GA-5' is a nontranscribed dinucleotide. Notably, the NS-M junction of VSV (NJ) does not contain the anomalous dinucleotide 3'-CA-5' which is found at the NS-M junction of VSV (IND). In striking contrast to VSV (IND), the G-L intergenic sequence of VSV (NJ) contains a 19-base insertion between the nontranscribed dinucleotide and the consensus mRNA start sequence. During in vitro transcription, the L mRNA of VSV (NJ) may initiate at two distinct sites: the first start site (3'-CCUUAUCUUC-5') is that flanking the nontranscribed dinucleotide, and the second start site is a consensus mRNA start sequence located 20 bases downstream from the nontranscribed dinucleotide. However, the L mRNA isolated form VSV (NJ)-infected cells appears to initiate only at the consensus start sequence. The possible role of these start sites in L mRNA synthesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820143     DOI: 10.1016/0042-6822(87)90048-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription.

Authors:  J N Barr; S P Whelan; G W Wertz
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions.

Authors:  L N Hwang; N Englund; A K Pattnaik
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene.

Authors:  A Kato; K Kiyotani; M K Hasan; T Shioda; Y Sakai; T Yoshida; Y Nagai
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Selection for gene junction sequences important for VSV transcription.

Authors:  Edward E Hinzman; John N Barr; Gail W Wertz
Journal:  Virology       Date:  2008-09-09       Impact factor: 3.616

7.  Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription.

Authors:  Edward E Hinzman; John N Barr; Gail W Wertz
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.

Authors:  T Kurioka; K Mizutari; K Niwa; T Fukumori; M Inoue; M Hasegawa; A Shiotani
Journal:  Gene Ther       Date:  2015-09-11       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.